Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U2 small nuclear 22, pseudogene (RNU2-22P)
- Target
- RNU2-22P
- Molecular classification
- Pseudogene, Non-protein coding RNA, Small nuclear RNA (snRNA) pseudogene
01
Overview
RNU2-22P (RNA, U2 small nuclear 22, pseudogene) is a non-protein coding gene classified as a pseudogene. It represents a non-functional copy of a U2 small nuclear RNA gene, annotated in the human genome but neither expressed as a functional snRNA nor implicated in known biological processes or diseases. It is not a therapeutic target, nor does it have established relevance for drug interactions or clinical research.
- Other names
- RNU2-22PRNA, U2 small nuclear 22, pseudogene
02
Mechanism of action
None, as it has no confirmed role or interaction with drugs
03
Biological functions
As a pseudogene, no known biological function; it does not encode an active snRNA
04
Disease associations
None established; not implicated in disease as a functional molecule
05
Safety considerations
None; as a non-coding pseudogene, it is not considered a functional concern for safety or therapy
06
Interacting drugs
None reported; not a drug target
07
Biomarkers
None reported for patient selection or monitoring
Beyond the preview
Go deeper on RNA, U2 small nuclear 22, pseudogene (RNU2-22P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U2 small nuclear 22, pseudogene (RNU2-22P).